PHARMACEUTICS AND LIFE SCIENCE

Bladder Cancer Immunotherapy: AstraZeneca’s Imfinzi G..

Bladder cancer immunotherapy from AstraZeneca received its second FDA approval for resectable muscle-invasive disease. The Silicon Review reports on t...

How Does RTSM Improve Clinical Trial Management..

Conducting clinical trials is now more difficult than ever due of complex research designs, multiple study locations, and strict regulations. Still, u...

Lilly Flourishes in Q4 as Peer Projections Signal Loomi..

Eli Lilly capped 2025 with 45% revenue growth to $65.2B, driven by Mounjaro and Zepbound. But sector-wide data shows cooling optimism, with only 72% o...

Novo Nordisk Partners with Vivtex in Up to $2.1B Oral O..

Novo Nordisk partnered with MIT spinout Vivtex in a deal worth up to $2.1 billion to develop next-generation oral biologic drugs for obesity and diabe...

Pharma Firms Left Out of Trump Drug Deals Seek Entry..

Drugmakers excluded from the Trump administration’s latest drug-pricing agreements are lobbying for inclusion, fearing competitive disadvantage ...